EUVIMEDObjevte EUVIMED
Open access

Isolation and Analysis of Tumor‐Derived Exosomes

Nils Ludwig, Chang-Sook Hong, Sonja Ludwig, Juliana H Azambuja, Priyanka Sharma, Marie-Nicole Theodoraki, Theresa L Whiteside

Current Protocols in Immunology · 2019-12 · 127 (1)

DOI: 10.1002/cpim.91 ↗

At a glance

Journal article in Current Protocols in Immunology, published online on 2019-09-05. Written by Nils Ludwig and 6 co-authors. Institution: Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Cited 77 times so far (Crossref); 30 references. The full text is freely available in PubMed Central. Funded by: NCI NIH HHS, National Science Foundation, Deutsche Akademie der Naturforscher Leopoldina - Nationale Akademie der Wissenschaften.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

A method for isolation of exosomes from tumor cell supernatants or cancer patients’ plasma is presented. Tumor‐derived exosomes (TEX) are defined as a subset of extracellular vesicles (EVs) sized at 30 to 150 nm and originating from multivesicular bodies (MVBs). The method utilizes size exclusion chromatography (SEC) for recovery of exosomes from cell‐line supernatants or cancer patients’ plasma. The recovered exosomes are morphologically intact, aggregate‐free, and functionally competent. Their molecular content parallels that of the parent tumor cells and they carry various immunoregulatory ligands known to modulate functions of immune cells. All exosomes isolated from tumor cell lines are TEX, while those isolated from plasma of cancer patients have to be fractionated into TEX and non‐TEX. Mini‐SEC allows for exosome isolation and recovery in quantities sufficient for molecular profiling, functional studies, and, in the case of plasma, further fractionation into TEX and non‐TEX. The mini‐SEC method can also be used for comparative studies of the exosome content in serial specimens of cancer patients’ body fluids. © 2019 by John Wiley & Sons, Inc.

Subjects

MeSH terms (MEDLINE)

AnimalsCell FractionationCell Line, TumorChromatography, GelExosomesHumansMiceNeoplasms

Author keywords

TEXexosome isolationexosomessize exclusion chromatography

Authors and institutions

  • Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.
  • Department of Otolaryngology, University of Duisburg-Essen, Essen, Germany.
  • Programa de Pós-Graduação em Biociências, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Brazil.
  • Department of Otorhinolaryngology, Head and Neck Surgery, University of Ulm, Ulm, Germany.
  • Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.

Funding

  • NCI NIH HHS
  • National Science Foundation
  • Deutsche Akademie der Naturforscher Leopoldina - Nationale Akademie der Wissenschaften
  • Deutsche Forschungsgemeinschaft

Cite

APA

Ludwig, N., Hong, C. S., Ludwig, S., Azambuja, J. H., Sharma, P., Theodoraki, M. N., & Whiteside, T. L. (2019). Isolation and Analysis of Tumor‐Derived Exosomes. Current Protocols in Immunology, 127(1). https://doi.org/10.1002/cpim.91

Vancouver

Ludwig N, Hong CS, Ludwig S, Azambuja JH, Sharma P, Theodoraki MN, et al. Isolation and Analysis of Tumor‐Derived Exosomes. Current Protocols in Immunology. 2019;127(1). doi:10.1002/cpim.91

BibTeX
@article{Ludwig2019,
  author = {Ludwig, Nils and Hong, Chang-Sook and Ludwig, Sonja and Azambuja, Juliana H and Sharma, Priyanka and Theodoraki, Marie-Nicole and Whiteside, Theresa L},
  title = {Isolation and Analysis of Tumor‐Derived Exosomes},
  journal = {Current Protocols in Immunology},
  year = {2019},
  volume = {127},
  number = {1},
  doi = {10.1002/cpim.91}
}
Start for free →